These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19995151)

  • 21. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro.
    Vanhoecke BW; Bracke ME; Kloosterboer HJ; Depypere HT
    Maturitas; 2006 Jun; 54(3):229-37. PubMed ID: 16581209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
    Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
    Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
    Nas T; Sargon MF; Celik HH; Keskin PO; Gürsoy RH; Biberoglu K
    Saudi Med J; 2007 Dec; 28(12):1917-9. PubMed ID: 18060233
    [No Abstract]   [Full Text] [Related]  

  • 25. A case report of recurrent endometriosis following Tibolone hormone replacement therapy.
    Sundar SS; Gornall RJ; Kerr-Wilson R; Swingler GR; Kinder RB; McCarthy K
    J Obstet Gynaecol; 2007 May; 27(4):433-4. PubMed ID: 17654209
    [No Abstract]   [Full Text] [Related]  

  • 26. Tibolone as Hormonal Therapy and Neuroprotective Agent.
    Del Río JP; Molina S; Hidalgo-Lanussa O; Garcia-Segura LM; Barreto GE
    Trends Endocrinol Metab; 2020 Oct; 31(10):742-759. PubMed ID: 32507541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy.
    Stuckey BG; Barrett PH; Wagner JM; Hampton RA; Chan DC; Brown SJ; Watts GF
    Clin Endocrinol (Oxf); 2010 Oct; 73(4):497-501. PubMed ID: 20560981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does tibolone exacerbate atherosclerosis?
    Clarkson TB
    Eur Heart J; 2006 Mar; 27(6):635-7. PubMed ID: 16415302
    [No Abstract]   [Full Text] [Related]  

  • 29. Carcinoma of the endometrium in patients treated with tibolone.
    Yazigi R; Sahid S; Contreras L; Rodriguez T
    Gynecol Oncol; 2004 May; 93(2):568-70. PubMed ID: 15099984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of hormonal replacement therapy on breast density in postmenopausal women].
    Bisanti T; Cavalieri AP; Capri O; Galoppi P; De Felice C; Porfiri LM; Perrone G
    Minerva Ginecol; 2004 Apr; 56(2):125-30. PubMed ID: 15258540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of tibolone on the quality of life, anxiety-depression levels and cognitive functions in natural menopause: an observational follow-up study.
    Gülseren L; Kalafat D; Mandaci H; Gülseren S; Camli L
    Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):71-3. PubMed ID: 15730370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tibolone: a unique version of hormone replacement therapy.
    Swegle JM; Kelly MW
    Ann Pharmacother; 2004 May; 38(5):874-81. PubMed ID: 15026563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tibolone.
    Reynir Tomas G
    Acta Obstet Gynecol Scand; 2004 Jun; 83(6):606. PubMed ID: 15144349
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tibolone therapy in postmenopausal women with a history of many risk factors].
    Szántó F
    Orv Hetil; 2003 Apr; 144(15):701-4. PubMed ID: 12774429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The short-term effect of increased body weight in menopausal Chinese women taking tibolone.
    Wang PH; Yen MS; Chao KC; Liu CM; Lee WL
    Maturitas; 2008 Mar; 59(3):281-2; author reply 282-3. PubMed ID: 18281168
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of tibolone on endogenous nitric oxide (nitrite/nitrate levels) in postmenopausal women.
    Akgül C; Canbaz M; Vural P
    Int J Fertil Womens Med; 2002; 47(1):13-7. PubMed ID: 11900269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
    Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tibolone-induced hepatotoxicity].
    Blanco Sampascual S; de Las Heras Niño B; Cabezudo Gil P; Ruiz Eguiluz P; Orive Cura V
    Gastroenterol Hepatol; 2002 Apr; 25(4):274. PubMed ID: 11975880
    [No Abstract]   [Full Text] [Related]  

  • 39. Hormonal environment in the induction of breast cancer in castrated rats using dimethylbenzanthracene: influence of the presence or absence of ovarian activity and of treatment with estradiol, tibolone, and raloxifene.
    Callejo J; Cano A; Medina M; Villaronga M; Gonzalez-Bosquet E; Sabria J; Lailla JM
    Menopause; 2005; 12(5):601-8. PubMed ID: 16145314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does tibolone affect serum leptin levels and body weight in postmenopausal women?
    Gol M; Ozsener S; Sendag F; Uretmen S; Oztekin K; Tanyalcin T; Bilgin O
    Arch Gynecol Obstet; 2005 Jul; 272(2):127-30. PubMed ID: 15517326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.